| Product Code: ETC9927551 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Monogenic Disease Testing Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Monogenic Disease Testing Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Monogenic Disease Testing Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United Arab Emirates (UAE) Monogenic Disease Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of monogenic diseases in the United Arab Emirates |
4.2.2 Growing awareness about genetic testing and personalized medicine |
4.2.3 Supportive government initiatives and policies promoting genetic testing in healthcare |
4.3 Market Restraints |
4.3.1 Limited availability of skilled professionals for genetic testing |
4.3.2 High cost associated with genetic testing services |
4.3.3 Lack of comprehensive insurance coverage for genetic testing |
5 United Arab Emirates (UAE) Monogenic Disease Testing Market Trends |
6 United Arab Emirates (UAE) Monogenic Disease Testing Market, By Types |
6.1 United Arab Emirates (UAE) Monogenic Disease Testing Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Carrier Testing, 2021- 2031F |
6.1.4 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Diagnostic Testing, 2021- 2031F |
6.1.5 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By New-Born Screening, 2021- 2031F |
6.1.6 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Predictive and Pre-Symptomatic Testing, 2021- 2031F |
6.1.7 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Prenatal Testing, 2021- 2031F |
6.2 United Arab Emirates (UAE) Monogenic Disease Testing Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Cystic fibrosis, 2021- 2031F |
6.2.3 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Sickle Cell Anemia, 2021- 2031F |
6.2.4 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Severe Combined Immunodeficiency (SCID), 2021- 2031F |
6.2.5 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Tay-Sachs Disorder, 2021- 2031F |
6.2.6 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Polycystic Kidney Disorder, 2021- 2031F |
6.2.7 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Arab Emirates (UAE) Monogenic Disease Testing Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenues & Volume, By Specialized Clinics, 2021- 2031F |
7 United Arab Emirates (UAE) Monogenic Disease Testing Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Monogenic Disease Testing Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Monogenic Disease Testing Market Imports from Major Countries |
8 United Arab Emirates (UAE) Monogenic Disease Testing Market Key Performance Indicators |
8.1 Number of genetic testing laboratories in the UAE |
8.2 Percentage of healthcare providers offering monogenic disease testing |
8.3 Adoption rate of genetic testing technologies in healthcare settings |
9 United Arab Emirates (UAE) Monogenic Disease Testing Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Monogenic Disease Testing Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Monogenic Disease Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Monogenic Disease Testing Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United Arab Emirates (UAE) Monogenic Disease Testing Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Monogenic Disease Testing Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Monogenic Disease Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here